| 000 | 00858 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250514221823.0 | ||
| 264 | 0 | _c20060221 | |
| 008 | 200602s 0 0 spa d | ||
| 022 | _a0212-6567 | ||
| 024 | 7 |
_a10.1157/13072596 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVázquez Gómez, I | |
| 245 | 0 | 0 |
_a[Response of the pharmaceutical industry to a specific consultation]. _h[electronic resource] |
| 260 |
_bAtencion primaria _cMar 2005 |
||
| 300 |
_a219-20 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aDrug Industry |
| 650 | 0 | 4 | _aInformation Dissemination |
| 650 | 0 | 4 | _aReferral and Consultation |
| 700 | 1 | _aFernández-Llimos, F | |
| 700 | 1 | _aGastelurrutia, M A | |
| 773 | 0 |
_tAtencion primaria _gvol. 35 _gno. 4 _gp. 219-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1157/13072596 _zAvailable from publisher's website |
| 999 |
_c15439259 _d15439259 |
||